Cargando…
1219. Utility of Plasma Microbial Cell-Free DNA Testing for Therapeutic Management and Antimicrobial Stewardship
BACKGROUND: Microbial cell-free DNA (mcfDNA) sequencing is a promising potential tool in the detection of infectious pathogens when traditional methods fail to identify the causative agent. It may be particularly helpful in identifying pathogens that are present at low levels or that do not grow wel...
Autores principales: | Thompson, Riley, Donnelley, Monica, Thompson, George R, Desai, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678802/ http://dx.doi.org/10.1093/ofid/ofad500.1059 |
Ejemplares similares
-
54. The Effect of Targeting High-Risk Patients for Antimicrobial Stewardship Intervention on Hospital-Onset Clostridioides Difficile Infection Rates
por: Yang, Albert, et al.
Publicado: (2021) -
Amendment to document "Health Insurance Scheme" (CERN/FC/1219)
Publicado: (1970) -
Oleoyl Coenzyme A Regulates Interaction of Transcriptional Regulator RaaS (Rv1219c) with DNA in Mycobacteria
por: Turapov, Obolbek, et al.
Publicado: (2014) -
Antibiotic Utilization and Antimicrobial Stewardship in Community Hospitals
por: Thabit, Abrar, et al.
Publicado: (2017) -
327. Understanding Current Clinical Scenarios for Plasma Microbial Cell-free DNA Diagnostic Testing toward Informing Diagnostic Stewardship
por: Lau, Constance, et al.
Publicado: (2022)